AbbVie Inc. — Ethics Grade C-

AbbVie Inc. receives an overall ethics grade of C- (40/100) on CancelCo's corporate accountability database. Sector: Pharmaceuticals. Market cap: Large Cap.

Category scores

• labor: 50
• privacy: 55
• consumer: 10
• environment: 50
• humanRights: 40

Documented incidents (2)

• Humira patent thicket (high, 2023) — Built 132-patent wall around Humira to block generics, keeping drug prices at $80K/year for two decades while it cost a few hundred to produce.
• Foreign bribery settlements (high, 2022) — Paid $315M to settle charges of bribing foreign doctors and officials to prescribe its drugs in multiple countries.

Documented good deeds

• AbbVie Foundation giving — Donated $40M+ through AbbVie Foundation for STEM education and health equity programs.

Ethical alternatives

• Civica Rx — Non-profit generic drug company making essential medicines affordable.